FDA Classification Prevents Emergency Authorization For Potential Zika Prevention Technology
News Summary
The Hill: FDA’s hostility blocks Zika-prevention technology Henry I. Miller, physician, fellow at Stanford University’s Hoover Institution, and founding director of the Office of Biotechnology at the FDA, and Drew L. Kershen, professor at the University of Oklahoma College of Law “…One promising unapproved ‘drug’ that could control the vector…